Vemurafenib‐Induced Neutrophilic Panniculitis in a Child with a Brainstem Glioma | Zendy

West Emily S. | Zendy; Williams Victoria L. | Zendy; Morelli Joseph G. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Vemurafenib‐Induced Neutrophilic Panniculitis in a Child with a Brainstem Glioma

Author(s) -

West Emily S.,

Williams Victoria L.,

Morelli Joseph G.

Publication year - 2014

Publication title -

pediatric dermatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.542

H-Index - 73

eISSN - 1525-1470

pISSN - 0736-8046

DOI - 10.1111/pde.12316

Subject(s) - vemurafenib , medicine , panniculitis , dermatology , glioma , adverse effect , girl , brainstem , cancer research , cancer , metastatic melanoma , psychology , developmental psychology

Neutrophilic panniculitis is a rare adverse effect of therapy with selective BRAF inhibitors. We report a case of neutrophilic panniculitis in a 15‐year‐old girl receiving treatment with vemurafenib for a brainstem glioma. Clinicians should be aware of this rare but important side effect of vemurafenib. This is the first report of neutrophilic panniculitis in a child treated with vemurafenib.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research